Consolidated quarterly revenue nearly doubled
Quarter revenue is a strong starting point, not a cash-flow proxy
Watch: Check sell-through and receivables
Home / Research / Aditya Infotech Limited
Consolidated quarterly revenue nearly doubled
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf
Quarter revenue is a strong starting point, not a cash-flow proxy
Watch: Check sell-through and receivables
Compare the same half-year periods and accounting basis
Watch: Review H2 growth normalisation
The 17.6% margin is not management's H2 run rate
Watch: Stress test input costs
The six-month result is more useful than a single quarter for the operating trajectory
Watch: Track second-half profitability
Aditya Infotech Limited (NSE: CPPLUS) | Q2 and H1 FY2027 | Quarter ended 30 September 2026 | Consolidated, unaudited
Decision stance: WATCH. The quarter establishes unusually rapid revenue growth, a higher operating margin and stronger reported market positioning in Indian video surveillance. The crucial question is not whether Q2 was strong; it is how much of that performance can persist once input-cost protection, certified-camera demand and channel inventory normalise. The company itself cautioned that Q2's 17.6% EBITDA margin should not be treated as the second-half run rate. [S1][S2]
| Decision metric | Q2 FY27 | Q2 FY26 | Interpretation |
|---|---|---|---|
| Consolidated revenue (₹ crore) | 1,746.0 | 919.6 | +89.9% YoY |
| EBITDA (₹ crore) | 307.4 | 111.1 | +176.7% YoY |
| EBITDA margin | 17.6% | 12.0% | +552 basis points |
| PAT before exceptional item (₹ crore) | 219.9 | 70.0 | +214.2% YoY; management's adjusted measure |
| Reported PAT (₹ crore) | 185.5 | 70.0 | +165.1% YoY; includes ₹34.4 crore fire loss |
The comparison above uses the same consolidated accounting basis for each period. The investor presentation defines gross margin on revenue and other margins on total income; these denominators should not be silently interchanged. [S2]
Six investor takeaways
Investment decision rule. Without a contemporaneous share price, enterprise value, share count and consistent forward earnings bridge in these two sources, no numeric target price or fair-value multiple is asserted. A premium valuation would require evidence that market-share gains survive a lower margin environment, inventory unwinds without discounting, and planned capacity generates acceptable cash returns. A cheaper headline multiple would not compensate for a structural decline in returns on new manufacturing capital. The separate chart briefing below is a source-backed diagnostic, not a price forecast.
The central investment debate is whether CP PLUS has built a defensible advantage in India's newly certified surveillance-camera market or is enjoying a temporary period of unusually favourable pricing, demand and stock availability. The issuer attributes its leadership to certified products, in-house manufacturing, own firmware, distribution breadth and its established brand.
The presentation estimates around 42% share of the Indian video-surveillance market in the trailing 12 months to September 2026, compared with approximately 30% at its FY25 IPO reference point. These are company estimates, not an independently reconstructed market-share series. [S2]
The operating evidence is compelling: revenue almost doubled, EBITDA grew substantially faster, and CP PLUS's contribution to group revenue rose. Yet the call contains an equally important caution. Management said component and input costs are volatile, that it had protected channels from abrupt price increases, and that the unusually high Q2 margin should not be annualised. Its unchanged 14–15% full-year margin guidance is a deliberate counterweight to the 17.6% quarterly outcome. [S1]
For an investor, the correct question is whether certified-product leadership can generate attractive *through-cycle* returns after distributor incentives, future price adjustments and manufacturing expansion. The QIP makes funding less constrained but introduces a second test: capital deployment must be productive, not simply large. Cash on the balance sheet should not be mistaken for recurring operating cash flow.
Decision takeaways
The consolidated financial table provides unusually clean same-period comparisons. Q2 revenue of ₹1,746.0 crore compares with ₹919.6 crore in Q2 FY26, while H1 revenue of ₹3,148.4 crore compares with ₹1,659.7 crore in H1 FY26. EBITDA was ₹307.4 crore against ₹111.1 crore in Q2 and ₹515.2 crore against ₹176.0 crore in H1. EBITDA margin advanced by 552 basis points in Q2 and 576 basis points in H1 according to the issuer's detailed table. [S2]
The gross-profit bridge helps identify where operating leverage is coming from. Q2 gross profit was ₹524.3 crore versus ₹274.0 crore, while gross margin was 30.0% versus 29.8%: only a modest 24-basis-point improvement. In contrast, H1 gross margin improved to 30.4% from 26.6%, a much larger 374-basis-point increase.
These are different time windows; it would be misleading to use H1's margin expansion as if it described Q2 alone. Employee costs increased to ₹124.9 crore from ₹82.9 crore in Q2, and other expenses to ₹96.0 crore from ₹82.5 crore, but revenue grew faster. [S2]
The earnings-quality distinction is essential. Q2 profit before tax before exceptional items was ₹286.2 crore versus ₹93.5 crore; after the ₹34.4 crore exceptional fire loss, reported PBT was ₹251.9 crore. The presentation reports Q2 PAT before the exceptional item at ₹219.9 crore and reported PAT at ₹185.5 crore.
H1 PAT before exceptional items was ₹362.1 crore versus ₹102.9 crore; reported H1 PAT was ₹327.7 crore. The fire-loss event occurred at AIL Dixon's Kadapa facility. Management said insurance covers the loss and a claim was lodged, but the filing excerpts do not establish a received cash reimbursement. [S1][S2]
The cost of debt is another useful bridge: Q2 finance costs declined to ₹6.0 crore from ₹6.9 crore, and H1 finance costs to ₹10.3 crore from ₹17.4 crore. Management indicated that October debt repayment would further affect the second half; that prospective effect is not included in the September-end balance sheet. H1 annualised ROCE of 34.3% versus 20.4% in H1 FY26 is encouraging, but a six-month annualisation is not the same as a full-cycle return. [S1][S2]
Financial takeaways
CP PLUS remains the group engine. Management said the brand accounted for approximately 88% of Q2 revenue, up from 86% a year earlier. Within CP PLUS, internet-protocol products were about 79% of the portfolio, compared with 71% earlier. These percentages refer to different denominators—brand share of group revenue and IP share within the CP PLUS portfolio—and must not be added or treated as two segments of a single mix chart. [S1]
The regulatory transition toward security-certified cameras changed the competitive environment. The presentation notes that OEMs could sell only certified cameras from April 2025 and that the sell-off of uncertified inventory ended in March 2026. The issuer says more than 100 CP PLUS models are STQC security-certified and that its manufacturing footprint can produce 2.5 million units per month. These are capability and compliance claims, not proof that all capacity is currently utilised or that every unit sold carries equal margin. [S2]
Distribution breadth supports the company's claim to leadership. In the call, management described roughly 30,000–35,000 installers and resellers connected to its incentive app and another 2,000 system integrators or installers engaged in projects. These counts describe relationships or reach, not verified active monthly purchasers. A broader installed and installer base could lower customer-acquisition friction, but channel stocking and receivable quality must be monitored as growth scales. [S1]
The secondary brands serve different price points. Management said NEXIVUE was gaining traction in the entry-to-mid segment, whereas EYRA had not yet meaningfully scaled. CP PLUS PRO is positioned for enterprise use. No comparable revenue or profit breakdown for EYRA, NEXIVUE or CP PLUS PRO was established in the selected source windows, so allocating group EBITDA to them would be invented precision. [S1]
Business-model takeaways
The ₹1,500 crore QIP is the pivot from a strong trading period to a capital-allocation test. The presentation states ₹1,465.5 crore net proceeds, with intended allocations of ₹325 crore toward repayment or prepayment of AIL and AIL Dixon borrowings, ₹650 crore for Kadapa Phase III and the Knowledge Park manufacturing plant, and ₹490.5 crore for acquisitions and general corporate purposes. These are allocations from the placement document, not proof that every project rupee has been spent. [S2]
Management said additional land of about 22 acres had been acquired for Kadapa Phase III and that land acquisition at Greater Noida was complete, with civil construction expected to begin subsequently. It indicated that capacity additions might come on line over 18–24 months, with a broader objective of roughly doubling capacity around late FY2029 to early FY2030. Those dates and the doubling ambition are forward-looking management statements, not current operating output. [S1]
The company also signed agreements dated 5 November 2026 for a ₹45.4 crore investment for a 30% fully diluted stake in BLUE KGraph AI Solutions, a video-compression technology business. Management described potential reductions of up to 90% in storage and bandwidth under relevant conditions, and a possible recurring software layer on the installed camera base.
Neither realised revenue from the stake nor a quantified payback period was provided in the selected evidence. The commercial value of this investment should therefore be judged on deployments and monetisation rather than headline technology claims. [S1][S2]
The analyst exchange raised useful constraints. On recorder certification, management explicitly said no new government notification had yet been issued for DVR/NVR products and would not quantify the impact until policy became clear. On the housing plant, it said expenditure had already occurred but could not provide a figure during the call. On working capital, management defended strategic inventory stocking while acknowledging that very rapid growth absorbs operating cash. These are genuine open monitoring questions rather than gaps to fill with estimates. [S1]
Execution takeaways
At 30 September 2026, consolidated cash and cash equivalents were ₹1,433.9 crore, total borrowings ₹362.7 crore, and net cash ₹1,071.2 crore. The presentation compares this with approximately ₹52 crore net cash at March 2026, but the intervening ₹1,500 crore QIP is a major financing inflow. The increase cannot be presented as internally generated cash. Management stated in the 6 November call that remaining borrowings were repaid in October; that is a post-balance-sheet statement, not the September-end borrowing number. [S1][S2]
Working-capital data show mixed signals. H1 FY27 receivable days were 96, compared with 121 for FY26, while inventory days were 111 versus 95. Payable days were 135 versus 138. The disclosed cash conversion cycle was 72 days versus 78. A six-day improvement in the cycle is helpful, but it coexists with a 16-day inventory build. Management attributed inventory positioning partly to strategic component purchasing and supply protection, and said that growth near 90% absorbs operating cash. [S1][S2]
The company also reports 34.3% annualised H1 ROCE and 26.9% annualised H1 ROE. Those return ratios reflect a period spanning a significant capital raise and should not be mechanically projected onto a much larger future asset base. The investment case needs a project-by-project return bridge once the ₹650 crore planned manufacturing allocation becomes productive. [S2]
The cited sources do not establish a reliable period cash-flow-statement reconciliation sufficient to quote precise H1 operating cash flow, free cash flow or capex cash paid here. Inventing those numbers would undermine the thesis. A rigorous next-quarter check should reconcile cash generated from operations, movement in inventories and trade receivables, project advances, and cash capex against management's growth narrative.
Capital and cash takeaways
Bull case — leadership becomes structurally profitable. Certified-camera adoption remains durable, CP PLUS maintains a meaningful share advantage, IP mix continues to improve and distribution scales without looser credit. Gross margins and cash conversion remain resilient even if the exceptional Q2 EBITDA margin moderates. Kadapa and Greater Noida capacity comes online in line with management's milestones, and BLUE produces identifiable customer benefits. This case would be supported by stable receivable days, an inventory unwind and disclosed returns on commissioned assets—not merely by more revenue growth. [S1][S2]
Base case — growth normalises while the franchise remains strong. The regulatory step-change is largely absorbed, channel growth slows from Q2's near-90% pace, and EBITDA margin moves toward the 14–15% full-year range guided by management. The business still benefits from a larger installed base and broader manufacturing footprint, but returns on incremental capital take time to prove. This is a conditional framing, not a financial forecast; no rupee earnings or valuation estimate is assigned. [S1]
Bear case — volume leadership masks deteriorating cash economics. Input costs rise, price increases lag, distributors hold excess inventory, or receivable days reverse. New plants add depreciation and working capital before meaningful utilisation, while the smaller brands compete more on price. The result could be lower margins and cash returns even if reported sales remain high. A further downside would be a delayed insurance recovery or poorly monetised acquisition spending. These are identified risk mechanisms, not predictions of specific losses.
Falsifiers and evidence thresholds
No target price, terminal growth rate, share-price return or future EPS is supplied because the selected filings do not establish a defensible full valuation model.
Current action: WATCH, with evidence-led review after the next results. The business has strong reported growth and profitability, but the two biggest underwriting uncertainties are sustainable post-transition margin and cash generation after a large capital raise. The next report should resolve those uncertainties before a higher-conviction investment decision.
| Monitoring test | Current issuer reference | What would change the assessment |
|---|---|---|
| Revenue durability | Q2 ₹1,746.0 crore; H1 ₹3,148.4 crore | Growth supported by sell-through and stable receivables, not stock loading |
| EBITDA margin | Q2 17.6%; H1 16.3%; FY27 guidance 14–15% | H2 actual margin and explanation of input-cost effects |
| Statutory versus adjusted PAT | Q2 ₹185.5 crore reported; ₹219.9 crore before fire loss | Insurance recovery and no recurring exceptional adjustments |
| Inventory discipline | H1 111 inventory days; FY26 95 | Stock normalisation without channel discounting |
| Receivables | H1 96 days; FY26 121 | Sustained collections despite new brand/channel expansion |
| Cash and borrowings | Sep net cash ₹1,071.2 crore; Oct repayment claimed | Reconciled operating cash flow and capex cash paid |
| Manufacturing investment | ₹650 crore intended QIP capex allocation | Commissioned capacity, utilisation and measured returns |
| Product/market position | IP share ~79%; issuer-estimated market share ~42% | Retention of certified-product leadership and improved unit economics |
Next-quarter work plan
Research limits that matter: The issuer's own market-share estimate is not independently validated here; product-level profit margins, a reconciled operating cash-flow statement, detailed project paybacks, current share valuation and insurance cash receipts are not established in the two cited documents. Management outlook is identified as such. These omissions affect the investment decision and are not replaced with assumed numbers.
All financial amounts above are in Indian rupees crore unless otherwise specified. The financial tables are consolidated and unaudited; references to guidance, market-share estimates and project timelines are explicitly management statements.
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf
https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46823a7d-6dc1-415f-8023-72ef1c3bf70b.pdf
This is dated research, not a live market quote. Scenarios and historical performance are not guarantees.